Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance

  1. Hofmann, M.H.
  2. Mani, R.
  3. Engelhardt, H.
  4. Impagnatiello, M.A.
  5. Carotta, S.
  6. Kerenyi, M.
  7. Lorenzo-Herrero, S.
  8. Böttcher, J.
  9. Scharn, D.
  10. Arnhof, H.
  11. Zoephel, A.
  12. Schnitzer, R.
  13. Gerstberger, T.
  14. Sanderson, M.P.
  15. Rajgolikar, G.
  16. Goswami, S.
  17. Vasu, S.
  18. Ettmayer, P.
  19. Gonzalez, S.
  20. Pearson, M.
  21. McConnell, D.B.
  22. Kraut, N.
  23. Muthusamy, N.
  24. Moll, J.
Journal:
Molecular cancer therapeutics

ISSN: 1538-8514

Year of publication: 2020

Volume: 19

Issue: 4

Pages: 1018-1030

Type: Article

DOI: 10.1158/1535-7163.MCT-19-0789 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals